[HTML][HTML] Chlamydia trachomatis: Cell biology, immunology and vaccination

SM Murray, PF McKay - Vaccine, 2021 - Elsevier
Chlamydia trachomatis is the causative agent of a highly prevalent sexually transmitted
bacterial disease and is associated with a number of severe disease complications. Current …

Programmes, partnerships, and governance for elimination and control of neglected tropical diseases

B Liese, M Rosenberg, A Schratz - The Lancet, 2010 - thelancet.com
Neglected tropical diseases represent one of the most serious burdens to public health.
Many can be treated cost-effectively, yet they have been largely ignored on the global health …

[PDF][PDF] Mapping the global distribution of trachoma

S Polack, S Brooker, H Kuper… - Bulletin of the World …, 2005 - SciELO Public Health
OBJECTIVE: We aimed to summarize and map the existing global population-based data on
active trachoma and trichiasis. Detailed distribution maps of various infectious diseases …

Control of neglected tropical diseases needs a long-term commitment

Y Zhang, C MacArthur, L Mubila, S Baker - BMC medicine, 2010 - Springer
Background Neglected tropical diseases are widespread, particularly in sub-Saharan Africa,
affecting over 2 billion individuals. Control of these diseases has gathered pace in recent …

Chlamydial eye infections: Current perspectives

G Satpathy, HS Behera, NH Ahmed - Indian journal of …, 2017 - journals.lww.com
Chlamydia trachomatis, an obligate intraocular bacteria causing trachoma, adult and
neonatal inclusion conjunctivitis, was the leading cause of blindness in the last century …

Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey

SK West, B Munoz, J Weaver, Z Mrango… - PLoS neglected …, 2016 - journals.plos.org
Background Trachoma is targeted for elimination by 2020. World Health Organization
advises districts to undertake surveillance when follicular trachoma (TF)< 5% in children 1–9 …

Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration

EB Goodhew, SMG Morgan, AJ Switzer, B Munoz… - BMC infectious …, 2014 - Springer
Background Blinding trachoma, caused by the bacteria Chlamydia trachomatis, is a
neglected tropical disease targeted for elimination by 2020. A major component of the …

Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks

RJ Rolfe, H Shaikh, LG Tillekeratne - Infectious Diseases of Poverty, 2022 - Springer
Background Mass drug administration (MDA) is a strategy to improve health at the
population level through widespread delivery of medicine in a community. We surveyed the …

Effectiveness of azithromycin mass drug administration on trachoma: a systematic review

T Xiong, Y Yue, WX Li, I Choonara, S Qazi… - Chinese medical …, 2021 - mednexus.org
Backgrounds: Azithromycin mass drug administration (MDA) is a key part of the strategy for
controlling trachoma. This systematic review aimed to comprehensively summarize the …

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia

H Pickering, A Chernet, E Sata… - The Journal of …, 2022 - academic.oup.com
Background To eliminate trachoma as a public health problem, the World Health
Organization recommends the SAFE (surgery, antibiotics, facial cleanliness, and …